These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3112329)

  • 1. Digital angiographic quantification of blood flow dynamics in embolic stroke treated with tissue-type plasminogen activator.
    Kissel P; Chehrazi B; Seibert JA; Wagner FC
    J Neurosurg; 1987 Sep; 67(3):399-405. PubMed ID: 3112329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of recombinant tissue plasminogen activator in embolic stroke.
    Chehrazi BB; Seibert JA; Kissel P; Hein L; Brock JM
    Neurosurgery; 1989 Mar; 24(3):355-60. PubMed ID: 2494563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke.
    Papadopoulos SM; Chandler WF; Salamat MS; Topol EJ; Sackellares JC
    J Neurosurg; 1987 Sep; 67(3):394-8. PubMed ID: 3112328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and angiographic efficacy of tissue plasminogen activator in a cerebral embolization model.
    Phillips DA; Fisher M; Smith TW; Davis MA
    Ann Neurol; 1988 Apr; 23(4):391-4. PubMed ID: 3132892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Direct continuous observation of in situ thrombolysis in the cerebral embolic model of rabbits].
    Kashiwabara S; Kurokawa Y; Uede T; Hashi K
    No To Shinkei; 1998 Apr; 50(4):347-54. PubMed ID: 9592824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of intra-arterial and intravenous tissue-type plasminogen activator on autologous arterial emboli in the cerebral circulation of rabbits.
    Hamilton MG; Lee JS; Cummings PJ; Zabramski JM
    Stroke; 1994 Mar; 25(3):651-5; discussion 656. PubMed ID: 8128521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits.
    Lyden PD; Zivin JA; Clark WA; Madden K; Sasse KC; Mazzarella VA; Terry RD; Press GA
    Neurology; 1989 May; 39(5):703-8. PubMed ID: 2496332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intravenous tissue-type plasminogen activator in a rat model of embolic cerebral ischemia.
    Penar PL; Greer CA
    Yale J Biol Med; 1987; 60(3):233-43. PubMed ID: 3111108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putaminal haemorrhage after recanalization of an embolic MCA occlusion treated with tissue plasminogen activator.
    Brückmann H; Ferbert A
    Neuroradiology; 1989; 31(1):95-7. PubMed ID: 2497402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator. Reduction of neurologic damage after experimental embolic stroke.
    Zivin JA; Lyden PD; DeGirolami U; Kochhar A; Mazzarella V; Hemenway CC; Johnston P
    Arch Neurol; 1988 Apr; 45(4):387-91. PubMed ID: 3128254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
    J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective embolization and clot dissolution with tPA in the internal carotid artery circulation of the rabbit.
    Phillips DA; Davis MA; Fisher M
    AJNR Am J Neuroradiol; 1988 Sep; 9(5):899-902. PubMed ID: 3140634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue plasminogen activator cerebrovascular thrombolysis in rabbits is dependent on the rate and route of administration.
    Russell D; Madden KP; Clark WM; Zivin JA
    Stroke; 1992 Mar; 23(3):388-93. PubMed ID: 1542901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THR-18, a 18-mer peptide derived from PAI-1, is neuroprotective and improves thrombolysis by tPA in rat stroke models.
    Krakovsky M; Polianski V; Nimrod A; Higazi A; Leker RR; Lamensdorf I
    Neurol Res; 2011 Nov; 33(9):983-90. PubMed ID: 22081002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging.
    Busch E; Krüger K; Allegrini PR; Kerskens CM; Gyngell ML; Hoehn-Berlage M; Hossmann KA
    J Cereb Blood Flow Metab; 1998 Apr; 18(4):407-18. PubMed ID: 9538906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke.
    Zhang L; Zhang ZG; Zhang R; Morris D; Lu M; Coller BS; Chopp M
    Circulation; 2003 Jun; 107(22):2837-43. PubMed ID: 12756151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator.
    Lapchak PA; Zivin JA
    Stroke; 2003 Aug; 34(8):2013-8. PubMed ID: 12855833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of complement by tissue plasminogen activator, but not acute cerebral ischemia, in a rabbit model of thromboembolic stroke.
    Bednar MM; Gross CE; Russell SR; Short D; Giclas PC
    J Neurosurg; 1997 Jan; 86(1):139-42. PubMed ID: 8988092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?].
    Kirchhof K; Sikinger M; Welzel T; Zoubaa S; Sartor K
    Rofo; 2004 Jan; 176(1):98-105. PubMed ID: 14712413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent embolization during intravenous administration of tissue plasminogen activator in acute cardioembolic stroke. A case report.
    Yasaka M; Yamaguchi T; Yonehara T; Moriyasu H
    Angiology; 1994 Jun; 45(6):481-4. PubMed ID: 8203776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.